TWO DEVICES. ENDLESS IMPACT.
Don’t guess! See the two biggest barriers to healing in real time.
SnapshotNIR + SnapshotGLO = clarity in care.
PORTABLE BACTERIA ASSESSMENT
*
PORTABLE BACTERIA ASSESSMENT *
SNAPSHOTGLO IS HERE! non-invasively assesses bacterial bioburden at the bedside.
REAL WORLD EVIDENCE STUDY
*
REAL WORLD EVIDENCE STUDY *
SnapshotNIR USED on 4,000+ wounds to deliver targeted care & improve healing outcomes
Better Clinical Decisions.
Better Together.
SnapshotNIR and SnapshotGLO work together to reveal two key barriers to healing—low tissue oxygenation and elevated bacterial bioburden. With dual imaging insights, clinicians gain clarity, confidence, and speed in decision-making, supporting earlier, more targeted interventions that optimize treatment, reduce delays, and help protect against complications.
Better data. Better outcomes. Better together.
July 14, 2026
ASSESSING HBOT WITH NIRS
It’s time to switch to a faster, more efficient way of assessing hyperbaric oxygen therapy. Plus, dive into the details of NIRS versus TCOM.
June 15, 2026
EPIC INTEGRATION + MORE!
Kent Imaging announces the latest software update to SnapshotNIR, featuring an integration with Epic EHR and a suite of improvements driven by clinician feedback.
SNapshot Suite: Bioburden Reduction and Improved Tissue Oxygenation in Fungating Melanoma Wound
Tyler Sexton, MD, MAPWCA
The Snapshot Suite revealed a substantial bacterial burden that was not visible through routine clinical assessment, demonstrating the limitations of visual inspection alone. Following conservative wound cleansing, SnapshotGLO confirmed near-complete bioburden eradication, while SnapshotNIR showed improved tissue oxygenation. By providing objective, real-time feedback on both bacterial burden and tissue oxygenation, the Snapshot Suite helps clinicians validate treatment effectiveness and make more confident, informed decisions at the point of care.
WOUND CARE
RECONSTRUCTIVE SURGERY